CRIVELLARO, CINZIA
 Distribuzione geografica
Continente #
NA - Nord America 9.299
AS - Asia 5.790
EU - Europa 4.618
SA - Sud America 892
AF - Africa 139
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 14
Totale 20.786
Nazione #
US - Stati Uniti d'America 9.020
SG - Singapore 1.881
IT - Italia 1.278
CN - Cina 1.218
VN - Vietnam 1.192
BR - Brasile 707
DE - Germania 640
HK - Hong Kong 622
RU - Federazione Russa 614
SE - Svezia 451
IE - Irlanda 320
GB - Regno Unito 269
FR - Francia 222
UA - Ucraina 200
CA - Canada 184
IN - India 176
AT - Austria 116
BD - Bangladesh 107
FI - Finlandia 95
TR - Turchia 89
ES - Italia 84
KR - Corea 74
IQ - Iraq 73
DK - Danimarca 63
AR - Argentina 59
PL - Polonia 58
NL - Olanda 57
MX - Messico 53
ID - Indonesia 51
JP - Giappone 49
EC - Ecuador 42
ZA - Sudafrica 40
PK - Pakistan 37
AU - Australia 32
CH - Svizzera 30
BE - Belgio 28
PH - Filippine 28
SA - Arabia Saudita 24
KE - Kenya 23
UZ - Uzbekistan 23
CZ - Repubblica Ceca 22
VE - Venezuela 21
CO - Colombia 20
MA - Marocco 19
JO - Giordania 16
PY - Paraguay 16
CL - Cile 13
JM - Giamaica 13
BG - Bulgaria 11
EG - Egitto 11
LT - Lituania 11
MY - Malesia 11
PS - Palestinian Territory 11
TH - Thailandia 11
AE - Emirati Arabi Uniti 10
OM - Oman 10
TN - Tunisia 10
AZ - Azerbaigian 9
PT - Portogallo 9
IR - Iran 8
RO - Romania 8
TW - Taiwan 8
EU - Europa 7
UY - Uruguay 7
AL - Albania 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
ET - Etiopia 6
GR - Grecia 6
IL - Israele 6
HU - Ungheria 5
KZ - Kazakistan 5
LB - Libano 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
CR - Costa Rica 4
GE - Georgia 4
HN - Honduras 4
LK - Sri Lanka 4
NG - Nigeria 4
NP - Nepal 4
SC - Seychelles 4
SN - Senegal 4
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MO - Macao, regione amministrativa speciale della Cina 3
NI - Nicaragua 3
PA - Panama 3
PE - Perù 3
SO - Somalia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CY - Cipro 2
GA - Gabon 2
GD - Grenada 2
KW - Kuwait 2
MD - Moldavia 2
Totale 20.754
Città #
Ann Arbor 1.578
Singapore 1.174
Ashburn 943
Hong Kong 582
San Jose 566
Chandler 466
Fairfield 455
Woodbridge 415
Milan 394
Frankfurt am Main 393
Ho Chi Minh City 385
Wilmington 359
Houston 350
Dublin 306
Hanoi 266
Dearborn 234
New York 231
Los Angeles 211
Seattle 195
Dallas 191
Santa Clara 185
Beijing 177
Jacksonville 169
Cambridge 161
Chicago 125
The Dalles 123
Hefei 117
Princeton 111
Shanghai 109
Lissone 100
Vienna 98
Nanjing 87
Lauterbourg 78
São Paulo 73
Seoul 64
Buffalo 62
Munich 62
Council Bluffs 55
Da Nang 54
Altamura 51
Moscow 50
Lawrence 49
Orem 49
London 43
Montreal 42
Guangzhou 40
Fremont 38
Boardman 37
Monza 37
Chennai 35
Haiphong 35
Toronto 35
Helsinki 34
Tokyo 34
Warsaw 34
Rome 33
San Diego 33
Ottawa 32
Jakarta 31
Brooklyn 29
Nanchang 29
Amsterdam 28
Atlanta 28
Johannesburg 28
Lachine 27
Nuremberg 27
Falls Church 26
Biên Hòa 24
Stockholm 24
Brussels 23
Jinan 23
Shenyang 23
Turku 23
Denver 22
Ha Long 22
Paris 22
Poplar 22
Baghdad 21
Dhaka 21
Dong Ket 21
Nairobi 21
Manchester 20
Rio de Janeiro 20
Boston 19
Mumbai 19
Tashkent 19
Andover 18
Hangzhou 18
Kunming 18
Tianjin 18
Brno 17
Ningbo 17
Ninh Bình 17
Pune 17
Bắc Ninh 16
Phoenix 16
Salt Lake City 16
Amman 15
City of London 15
Columbus 15
Totale 13.340
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 525
Cognitive profile and metabolic brain imaging in late-onset PCA compared with early-onset PCA and senile amnesic AD 520
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 468
A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease 454
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 445
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 438
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 430
18F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis 424
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 407
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 406
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration 399
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 385
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 360
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 358
Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction 350
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 349
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 344
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 343
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 343
Motion management in PET/CT: Technological solutions 340
Respiratory motion management in PET/CT: applications and clinical usefulness 339
Sentinel node biopsy in endometrial cancer: an update 337
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach 330
Neurocognitive heterogeneity of Posterior Cortical Atrophy 325
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 325
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 324
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 322
Metabolic subtypes of Posterior Cortical Atrophy: a data-driven approach controlling for pathophysiology-related hypometabolism 317
Mapping category fluency to the ventral and dorsal language streams in PCA and semantic and logopenic PPA 316
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 310
Anatomical correlates of reading in the elderly brain: an FDG-PET analysis of the reading performance in Alzheimer's Disease 310
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 309
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 308
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 306
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 302
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 293
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 287
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 277
Left and right corticobasal syndrome: comparison of cognitive profiles between metabolic imaging - matched groups 265
Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutation 263
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 261
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 260
Clinical and metabolic imaging features of late-onset and early-onset Posterior Cortical Atrophy 258
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 256
[ 11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: Comparison with bone scintigraphy 253
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 253
Cognitive profile of right and left Corticobasal Syndrome 251
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 249
Depressive Pseudodementia with Reversible AD-like Brain Hypometabolism: A Case Report and a Review of the Literature 247
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 246
Intrathoracic splenosis: Evaluation by 99mTc-labelled heat-denatured erythrocyte SPECT/CT 244
Focal bone lesions in hiv-positive patient treated with tenofovir 239
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 236
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 236
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 234
Comparative analysis of iterative reconstruction algorithms with resolution recovery for cardiac SPECT studies. A multi-center phantom study 234
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 232
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 222
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 221
PET-CT for treatment planning in prostate cancer 213
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum 207
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: validation on 18F-FDG PET data 191
Molecular imaging in prostate cancer: [11C]choline PET/CT 190
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 186
Clinical evidence on PET/CT for radiation therapy planning in prostate cancer 184
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 180
Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6 179
A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting 179
Respiratory Gating and the performance of PET/CT in pulmonary lesions 167
Cervical injection for sentinel lymph nodes detection in endometrial cancers is controversial: response to comments 167
PET-Guided target delineation in a patient with lung cancer. 130
Identification of Alzheimer’s disease with 18F-FDG-PET and MRI pCASL in MCI and SCD subjects: the CAPE study 100
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers 92
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 87
Totale 21.337
Categoria #
all - tutte 61.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 0 0 0 0 0 141 170
2021/20221.107 107 140 110 116 64 71 56 54 53 92 99 145
2022/20231.834 182 531 152 219 112 281 13 108 97 45 53 41
2023/20241.307 53 54 74 77 140 294 235 70 67 38 21 184
2024/20253.179 155 334 169 136 207 181 236 112 273 582 307 487
2025/20268.284 1.401 623 686 1.002 1.040 433 1.309 351 633 696 110 0
Totale 21.337